Overview

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)

Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the safety and effectiveness of an investigational drug and an approved drug in the treatment of osteoarthritis of the knee and hip.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Celecoxib
Etoricoxib
Criteria
Inclusion Criteria:

- Osteoarthritis of the knee or hip which requires treatment with a medication to obtain
pain relief

Exclusion Criteria:

- Any known allergy to the study drugs